Lora Oral Suspension 5 mg/5 ml

Lora Oral Suspension by Opsonin Pharma Ltd is a trusted antihistamine containing 5 mg/5 ml Loratadine. Priced at ৳30.20 per unit, this oral suspension treats allergic rhinitis, chronic urticaria, and skin allergies. Its non-sedative formula ensures 24-hour relief without drowsiness, making it ideal for daily use.

The suspension provides rapid symptom control for sneezing, nasal/ocular itching, and skin reactions. Approved for children above 2 years (dose-adjusted by weight), it maintains safety with minimal drug interactions. Store in cool, dry areas away from children. Avoid during pregnancy/lactation due to limited safety data.

Key advantages include:

• Once-daily dosing for convenience
• Alcohol-compatible formula
• No reported sedation in clinical trials

Adults & 12+ years: 5 ml (5 mg) once daily. 2-12 years: 5 ml if >30 kg, 2.5 ml if <30 kg. Below 2 years: Contraindicated. Administer in morning or as needed with food. Adjust dose in renal/hepatic impairment. Treatment duration should be physician-directed.

During controlled clinical studies the incidence of adverse events, including sedation and anticholinergic effects observed with 10 mg Lora was comparable to that observed with placebo. Studies on the effect of Lora on actual driving performance, and on tests of cognitive and psychomotor functioning have shown it to be comparable to placebo.

Pregnancy: Not recommended (insufficient safety data). Lactation: Contraindicated due to excretion in breast milk.

Dose adjustment needed in hepatic/renal impairment. Monitor liver function during prolonged use. No impairment in driving ability.

Geriatric: Adjust dose based on liver/kidney function. Pediatric: Weight-based dosing for 2-12 years. Renal: Avoid if eGFR <30. Hepatic: Max 10 mg/day in impairment.

In adults somnolence, tachycardia and headache have been reported with overdose greater than 10 mg. Extrapyramidal signs and palpitations have been reported in children with overdoses of greater than 10 mg. In the event of overdosage, general symptomatic and supportive measures should be instituted promptly and maintained for as long as necessary. It would seem reasonable to treat patients presenting early after large overdoses with oral activated charcoal. The conscious patients may be induced to vomit or gastric lavage may be performed.